Dr. Margaret Chang details the facility requirements for PDS implantation, the specialized training surgeons need, and crucial factors to consider for the surgical implantation of PDS.
What facilities are required to implant the device, and what specific training does a surgeon need?
What are the key considerations for the surgical implantation and subsequent refilling of the PDS?
What are the major adverse effects associated with the PDS, and which patients are not suitable candidates for this delivery system?
How does the PDS with ranibizumab fit into the treatment landscape that also includes highly durable agents such as faricimab and high-dose aflibercept?